Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
cyclobenzaprine aldehyde oxidase small molecule NA drugbank Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
NA approved inhibitor
cyclobenzaprine 5-hydroxytryptamine receptor 2a small molecule NA drugbank , DGIDB Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
0.52 approved antagonist
cyclobenzaprine 5-hydroxytryptamine receptor 2b small molecule NA drugbank Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
NA approved antagonist
cyclobenzaprine 5-hydroxytryptamine receptor 2c small molecule NA drugbank Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
NA approved antagonist
cyclobenzaprine 5-hydroxytryptamine receptor 6 small molecule NA drugbank Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
NA approved antagonist
cyclobenzaprine 5-hydroxytryptamine receptor 7 small molecule NA drugbank Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
NA approved antagonist
cyclobenzaprine sodium-dependent noradrenaline transporter small molecule NA drugbank Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
NA approved inhibitor
cyclobenzaprine sodium-dependent serotonin transporter small molecule NA drugbank Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
NA approved inhibitor
cyclobenzaprine toll-like receptor 4 small molecule NA drugbank Spinal Cord Diseases[MeSHID:D013118]
Spasm[MeSHID:D013035]
Fibromyalgia[MeSHID:D005356]
Cerebral Palsy[MeSHID:D002547]
Muscle Spasticity[MeSHID:D009128]
Sleep Disorders[MeSHID:D012893]
Rheumatism[MeSHID:D012216]
Off-Label Use[MeSHID:D056687]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Mental Depression[MeSHID:D003863]
Depressive disorder[MeSHID:D003866]
NA approved inhibitor
click here to return to the previous page